Splinting vs Exercise in De Quervain's Tenosynovitis
Launched by KONYA BEYHEKIM TRAINING AND RESEARCH HOSPITAL · May 21, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at two common treatments for De Quervain's tenosynovitis, a condition that causes pain in the wrist and thumb. The study aims to compare the effectiveness of wearing a splint to keep the wrist still versus doing specific exercises to help with pain and function. Participants will be assessed on various factors, including their pain levels, how well they can use their hands, and overall satisfaction with the treatment.
To be eligible for this trial, participants should be adults aged 18 to 65 who have been experiencing wrist pain for less than three months and have a certain level of pain. However, people with a history of wrist fractures, infections, or certain medical conditions like arthritis may not qualify. If you join the trial, you can expect to receive either a splint or an exercise program and will be monitored to see how well each treatment works for managing your symptoms. This study is currently recruiting participants, so it’s an excellent opportunity for those struggling with this condition to explore a potential path to relief.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adults aged between 18 and 65 years
- • Patients experiencing wrist pain and tenderness for less than 3 months and clinically diagnosed with acute or subacute De Quervain's tenosynovitis
- • Visual Analog Scale (VAS) pain score ≥ 3
- Exclusion Criteria:
- • History of trauma
- • Wrist fractures
- • Local infection
- • Presence of rheumatologic diseases (e.g., rheumatoid arthritis, psoriatic arthritis)
- • Presence of symptomatic hand osteoarthritis
- • Continuous use of nonsteroidal anti-inflammatory drugs (NSAIDs) or corticosteroids
- • Receipt of physical therapy for the hand or wrist within the past 3 months
- • Corticosteroid injection into the hand or wrist within the past 3 months
- • Diagnosed with significant neurological disorders (e.g., upper motor neuron disease)
- • Presence of uncontrolled systemic diseases (e.g., uncontrolled diabetes mellitus, congestive heart failure, chronic kidney disease, hepatic failure)
- • Major psychiatric disorders
- • Communication difficulties
About Konya Beyhekim Training And Research Hospital
Konya Beyhekim Training and Research Hospital is a leading healthcare institution in Turkey dedicated to advancing medical knowledge and improving patient care through innovative research and clinical trials. Committed to excellence in training and education, the hospital serves as a pivotal center for medical professionals, fostering an environment of collaboration and scientific inquiry. With state-of-the-art facilities and a multidisciplinary team of experts, Konya Beyhekim aims to contribute significantly to the advancement of medical science and the development of new therapies, ensuring the highest standards of patient safety and ethical research practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Konya, , Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported